2022-09-01 2023-08-31 false No description of principal activity Debitam - Tax and Accounts 1.0 13581609 bus:FullAccounts 2022-09-01 2023-08-31 13581609 bus:Micro-entities 2022-09-01 2023-08-31 13581609 bus:AuditExempt-NoAccountantsReport 2022-09-01 2023-08-31 13581609 bus:SmallCompaniesRegimeForAccounts 2022-09-01 2023-08-31 13581609 bus:PrivateLimitedCompanyLtd 2022-09-01 2023-08-31 13581609 2022-09-01 2023-08-31 13581609 2023-08-31 13581609 bus:RegisteredOffice 2022-09-01 2023-08-31 13581609 core:WithinOneYear 2023-08-31 13581609 core:AfterOneYear 2023-08-31 13581609 2021-08-24 13581609 bus:Director1 2022-09-01 2023-08-31 13581609 bus:Director1 2023-08-31 13581609 bus:Director1 2021-08-24 2022-08-31 13581609 bus:Director2 2022-09-01 2023-08-31 13581609 bus:Director2 2023-08-31 13581609 bus:Director2 2021-08-24 2022-08-31 13581609 bus:CompanySecretary1 2022-09-01 2023-08-31 13581609 bus:LeadAgentIfApplicable 2022-09-01 2023-08-31 13581609 2021-08-24 2022-08-31 13581609 2022-08-31 13581609 core:WithinOneYear 2022-08-31 13581609 core:AfterOneYear 2022-08-31 13581609 bus:EntityAccountantsOrAuditors 2021-08-24 2022-08-31 13581609 core:OfficeEquipment 2022-09-01 2023-08-31 13581609 core:OfficeEquipment 2023-08-31 13581609 core:OfficeEquipment 2022-08-31 13581609 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-08-31 13581609 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2022-08-31 13581609 core:CostValuation core:Non-currentFinancialInstruments 2023-08-31 13581609 core:CostValuation core:Non-currentFinancialInstruments 2022-08-31 13581609 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-08-31 13581609 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-08-31 13581609 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-08-31 13581609 core:Non-currentFinancialInstruments 2023-08-31 13581609 core:Non-currentFinancialInstruments 2022-08-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 13581609
England and Wales

 

 

 


Report of the Directors and Unaudited Financial Statements

for the year ended 31 August 2023

for

BURLINGTON PHARMA LTD

 
 
 
£
2023
£
   
£
2022
£
Fixed assets 3,298 
Current assets 41,463  17,809 
Creditors: amount falling due within one year (33,844) (25,710)
Net current assets 7,619  (7,901)
Total assets less current liabilities 10,917  (7,901)
Net assets 10,917  (7,901)
 
Capital and reserves 10,917  (7,901)
 
  1. For the year ended 31 August 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the companies act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts
The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Signed on behalf of the board of directors:


----------------------------------
Cheung Hoe Leong
Director

Date approved: 24 April 2024
1
Statutory Information
BURLINGTON PHARMA LTD is a private limited company, limited by shares, domiciled in England and Wales, registration number 13581609, registration address 167-169 Great Portland Street, 5th Floor, London, W1W 5PF, England.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
2.

Tangible fixed assets

Cost or Valuation Office Equipment   Total
  £   £
At 01 September 2022  
Additions 4,122    4,122 
Disposals  
At 31 August 2023 4,122    4,122 
Depreciation
At 01 September 2022  
Charge for year 824    824 
On disposals  
At 31 August 2023 824    824 
Net book values
Closing balance as at 31 August 2023 3,298    3,298 
Opening balance as at 01 September 2022  

3.

Average number of employees

Average number of employees during the year was 0  (2022: 0).
2